AVTR icon

Avantor

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 94.1%
Negative

Neutral
Newsfile Corp
12 hours ago
Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 15, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Avantor, Inc. (NYSE: AVTR) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Avantor caused the company to misrepresent or fail to disclose that: (1) Avantor's competitive positioning was weaker than had been publicly represented; (2) Avantor was experiencing negative effects from increased competition; and (3) as a result, representations about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.
Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm
Positive
Seeking Alpha
13 hours ago
Longleaf Partners Global Fund 2025 Contributors And Detractors
French pay-TV operator Canal+ was a contributor for the year. After a tough start in 2025, momentum in Glanbia's core Performance Nutrition business improved from low single-digit growth rates. Millicom extended its strong 2024 performance through 2025, with the share price tracking operational delivery and the visible inflection in equity FCF we flagged in prior letters.
Longleaf Partners Global Fund 2025 Contributors And Detractors
Neutral
Seeking Alpha
yesterday
Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral
Business Wire
2 days ago
p-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor
CHICAGO--(BUSINESS WIRE)-- #Biotech--Trial will demonstrate advanced traceability of drugs for Oncology, Urology, Rheumatology and Gastroenterology across pharmaceutical supply chain.
p-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor
Neutral
PRNewsWire
3 days ago
Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026
RADNOR, Pa., Jan. 12, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February, 11, and will hold a conference call to discuss the results on the same day at 8:00 a.m.
Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026
Negative
Zacks Investment Research
7 days ago
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
AVTR looks worth holding as its broad portfolio, strategic deals and cost savings offset Lab Solutions' weakness for now with AI tools and strong cash flow.
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
Neutral
PRNewsWire
10 days ago
Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference
RADNOR, Pa., Jan. 5, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Emmanuel Ligner, President and CEO, will present at the 44th Annual J.P.
Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference
Positive
The Motley Fool
13 days ago
Avantor Stock Down 46% This Past Year, but One Fund's $23 Million Bet Signals Turnaround Potential
Chicago-based Kinney Asset Management increased its Avantor position by 470,000 shares in the third quarter. The overall position value went up by about $4.52 million compared to the previous period.
Avantor Stock Down 46% This Past Year, but One Fund's $23 Million Bet Signals Turnaround Potential
Neutral
GlobeNewsWire
17 days ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 29, 2025 in Avantor, Inc. Lawsuit – AVTR
NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Avantor, Inc. ("Avantor, Inc." or the "Company") (NYSE: AVTR) of a class action securities lawsuit.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 29, 2025 in Avantor, Inc. Lawsuit – AVTR
Neutral
GlobeNewsWire
17 days ago
AVANTOR FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Avantor Stockholders of the December 29th Deadline and Urges Investors to Contact the Firm
Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Avantor (AVTR) To Contact Him Directly To Discuss Their Options
AVANTOR FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Avantor Stockholders of the December 29th Deadline and Urges Investors to Contact the Firm